Climb Bio Stock Price History
CLYM Stock | 2.11 0.21 11.05% |
If you're considering investing in Climb Stock, it is important to understand the factors that can impact its price. As of today, the current price of Climb Bio stands at 2.11, as last reported on the 19th of August, with the highest price reaching 2.11 and the lowest price hitting 1.90 during the day. Climb Bio is risky given 3 months investment horizon. Climb Bio secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2 % return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.02% are justified by taking the suggested risk. Use Climb Bio Downside Deviation of 4.0, risk adjusted performance of 0.1529, and Mean Deviation of 3.83 to evaluate company specific risk that cannot be diversified away. At this time, Climb Bio's Other Stockholder Equity is very stable compared to the past year. As of the 19th of August 2025, Common Stock is likely to grow to 7,350, while Common Stock Shares Outstanding is likely to drop about 25.1 M. . As of the 19th of August 2025, Price Earnings Ratio is likely to drop to -1.23. In addition to that, Price Book Value Ratio is likely to drop to 0.39. Climb Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sharpe Ratio = 0.2019
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | CLYM | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.07 actual daily | 45 55% of assets are more volatile |
Expected Return
1.02 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Climb Bio is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Climb Bio by adding it to a well-diversified portfolio.
Climb Bio Stock Price History Chart
There are several ways to analyze Climb Stock price data. The simplest method is using a basic Climb candlestick price chart, which shows Climb Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | August 18, 2025 | 2.11 |
Lowest Price | May 27, 2025 | 1.17 |
Climb Bio August 19, 2025 Stock Price Synopsis
Various analyses of Climb Bio's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Climb Stock. It can be used to describe the percentage change in the price of Climb Bio from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Climb Stock.Climb Bio Price Rate Of Daily Change | 1.11 | |
Climb Bio Price Action Indicator | 0.21 | |
Climb Bio Price Daily Balance Of Power | 1.00 |
Climb Bio August 19, 2025 Stock Price Analysis
Climb Stock Price History Data
The price series of Climb Bio for the period between Wed, May 21, 2025 and Tue, Aug 19, 2025 has a statistical range of 0.94 with a coefficient of variation of 14.41. The prices are distributed with arithmetic mean of 1.38. The median price for the last 90 days is 1.3.Open | High | Low | Close | Volume | ||
08/19/2025 | 1.90 | 2.11 | 1.90 | 2.11 | ||
08/18/2025 | 1.97 | 2.15 | 1.93 | 2.11 | 1,649,266 | |
08/15/2025 | 1.73 | 1.93 | 1.73 | 1.90 | 1,144,758 | |
08/14/2025 | 1.62 | 1.72 | 1.61 | 1.72 | 394,663 | |
08/13/2025 | 1.65 | 1.69 | 1.60 | 1.63 | 376,373 | |
08/12/2025 | 1.63 | 1.68 | 1.55 | 1.61 | 481,653 | |
08/11/2025 | 1.71 | 1.72 | 1.64 | 1.65 | 368,678 | |
08/08/2025 | 1.72 | 1.75 | 1.66 | 1.70 | 259,475 | |
08/07/2025 | 1.75 | 1.76 | 1.66 | 1.68 | 265,363 | |
08/06/2025 | 1.77 | 1.77 | 1.63 | 1.75 | 689,200 | |
08/05/2025 | 1.74 | 1.85 | 1.68 | 1.74 | 1,257,544 | |
08/04/2025 | 1.68 | 1.78 | 1.66 | 1.70 | 4,650,920 | |
08/01/2025 | 1.41 | 1.46 | 1.36 | 1.45 | 145,406 | |
07/31/2025 | 1.51 | 1.52 | 1.39 | 1.40 | 163,071 | |
07/30/2025 | 1.51 | 1.57 | 1.50 | 1.52 | 94,737 | |
07/29/2025 | 1.59 | 1.64 | 1.50 | 1.51 | 248,664 | |
07/28/2025 | 1.46 | 1.65 | 1.46 | 1.60 | 765,743 | |
07/25/2025 | 1.48 | 1.51 | 1.43 | 1.45 | 114,661 | |
07/24/2025 | 1.41 | 1.53 | 1.40 | 1.48 | 98,000 | |
07/23/2025 | 1.42 | 1.48 | 1.38 | 1.48 | 59,600 | |
07/22/2025 | 1.43 | 1.44 | 1.38 | 1.41 | 64,817 | |
07/21/2025 | 1.52 | 1.53 | 1.40 | 1.41 | 219,853 | |
07/18/2025 | 1.47 | 1.55 | 1.45 | 1.51 | 158,633 | |
07/17/2025 | 1.41 | 1.51 | 1.40 | 1.46 | 237,844 | |
07/16/2025 | 1.38 | 1.43 | 1.37 | 1.40 | 190,710 | |
07/15/2025 | 1.38 | 1.42 | 1.35 | 1.37 | 82,100 | |
07/14/2025 | 1.35 | 1.45 | 1.35 | 1.42 | 165,418 | |
07/11/2025 | 1.34 | 1.39 | 1.32 | 1.37 | 245,400 | |
07/10/2025 | 1.35 | 1.39 | 1.32 | 1.35 | 137,400 | |
07/09/2025 | 1.25 | 1.37 | 1.25 | 1.35 | 594,300 | |
07/08/2025 | 1.26 | 1.31 | 1.21 | 1.26 | 262,233 | |
07/07/2025 | 1.31 | 1.34 | 1.23 | 1.26 | 159,301 | |
07/03/2025 | 1.26 | 1.32 | 1.24 | 1.28 | 158,800 | |
07/02/2025 | 1.19 | 1.28 | 1.19 | 1.26 | 170,809 | |
07/01/2025 | 1.24 | 1.25 | 1.19 | 1.19 | 211,107 | |
06/30/2025 | 1.20 | 1.25 | 1.20 | 1.24 | 182,474 | |
06/27/2025 | 1.26 | 1.29 | 1.18 | 1.18 | 2,555,326 | |
06/26/2025 | 1.25 | 1.34 | 1.23 | 1.26 | 183,077 | |
06/25/2025 | 1.28 | 1.34 | 1.23 | 1.30 | 220,900 | |
06/24/2025 | 1.20 | 1.30 | 1.20 | 1.29 | 412,301 | |
06/23/2025 | 1.22 | 1.25 | 1.17 | 1.20 | 250,599 | |
06/20/2025 | 1.24 | 1.25 | 1.18 | 1.21 | 186,735 | |
06/18/2025 | 1.23 | 1.29 | 1.16 | 1.23 | 282,430 | |
06/17/2025 | 1.25 | 1.31 | 1.20 | 1.20 | 190,200 | |
06/16/2025 | 1.29 | 1.31 | 1.21 | 1.27 | 161,383 | |
06/13/2025 | 1.24 | 1.30 | 1.21 | 1.26 | 167,293 | |
06/12/2025 | 1.26 | 1.30 | 1.21 | 1.28 | 133,358 | |
06/11/2025 | 1.36 | 1.37 | 1.26 | 1.26 | 194,081 | |
06/10/2025 | 1.30 | 1.40 | 1.30 | 1.37 | 158,102 | |
06/09/2025 | 1.41 | 1.45 | 1.31 | 1.34 | 252,900 | |
06/06/2025 | 1.40 | 1.47 | 1.30 | 1.39 | 1,001,019 | |
06/05/2025 | 1.30 | 1.30 | 1.22 | 1.24 | 70,360 | |
06/04/2025 | 1.30 | 1.36 | 1.28 | 1.29 | 77,675 | |
06/03/2025 | 1.18 | 1.30 | 1.18 | 1.29 | 179,300 | |
06/02/2025 | 1.18 | 1.22 | 1.16 | 1.18 | 113,477 | |
05/30/2025 | 1.20 | 1.23 | 1.17 | 1.18 | 106,276 | |
05/29/2025 | 1.23 | 1.28 | 1.19 | 1.22 | 114,913 | |
05/28/2025 | 1.16 | 1.27 | 1.16 | 1.25 | 256,500 | |
05/27/2025 | 1.24 | 1.24 | 1.16 | 1.17 | 101,399 | |
05/23/2025 | 1.20 | 1.23 | 1.17 | 1.18 | 178,600 | |
05/22/2025 | 1.22 | 1.24 | 1.17 | 1.20 | 135,100 |
About Climb Bio Stock history
Climb Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Climb is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Climb Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Climb Bio stock prices may prove useful in developing a viable investing in Climb Bio
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 48.2 M | 25.1 M |
Climb Bio Quarterly Net Working Capital |
|
Climb Bio Stock Technical Analysis
Climb Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
All Next | Launch Module |
Climb Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Climb Bio's price direction in advance. Along with the technical and fundamental analysis of Climb Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Climb to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1529 | |||
Jensen Alpha | 0.8155 | |||
Total Risk Alpha | 0.3569 | |||
Sortino Ratio | 0.2287 | |||
Treynor Ratio | 0.4837 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in commodities. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.